Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ritonavir in HIV-Associated Cutaneous Kaposi's Sarcoma
NCT00002366Phase 2Completed
- Sponsor
- Abbott Laboratories
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ritonavir in Kaposi sarcoma (KS), sponsored by Abbott Laboratories. Primary endpoints: Safety and Anti-Kaposi's sarcoma activity. Status: completed.
02
Drugs
ritonavir
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT00002366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002366.